Exploring the impact of circular RNA on ALS progression: A systematic review

• Published in: Brain research 2024-09, Vol.1838, p.148990, Article 148990
• Main Authors: Panchalingam, Santhiya, Kasivelu, Govindaraju
• Format: Article
• Language: English
• Subjects: ALS; Amyotrophic Lateral Sclerosis - genetics; Amyotrophic Lateral Sclerosis - metabolism; Animals; circRNA; Disease Progression; Genetic and environmental factors; Humans; Motor Neurons - metabolism; Neurodegenerative disease; Pathophysiology; RNA, Circular - genetics; RNA, Circular - metabolism
• ISSN: 0006-8993; 1872-6240; 1872-6240
• DOI: 10.1016/j.brainres.2024.148990

[Display omitted] •Circular RNAs as potential blood biomarkers for Amyotrophic Lateral Sclerosis.•Circular RNA dysregulation is associated with various neurodegenerative diseases and myopathies.•Understanding the genetic and environmental (GXE) interactions in ALS disease.•Pathophysiological implications of Circular RNAs in the Nervous System.•Insilico and experimental identification and characterization of circular RNAs. Amyotrophic lateral sclerosis is a neurodegenerative disease that damages motor neurons and causes gradual muscular weakening and paralysis. Although studies have linked a number of genetic and environmental factors to ALS, the specific causes and mechanisms of the disease are still unclear. The pivotal role of circular RNA in the pathogenesis of ALS is a newly emerging area of research. The term “circular RNA” describes a particular class of RNA molecule that, in contrast to most RNA molecules, has a closed-loop structure. According to recent research, circular RNA might be essential for the development and progression of ALS. It has been discovered that these circular RNAs support important cellular functions related to ALS, including protein turnover, mitochondrial function, RNA processing, and cellular transport. Gaining knowledge about the precise roles and processes of circular RNA in the development of ALS could assist in understanding the pathophysiology of the disease and possibly pave the way for the development of targeted therapies. However, the understanding of circular RNA in ALS is still limited, and more research is needed to fully elucidate its role. In order to gain a comprehensive understanding of the role of circRNAs in ALS, it is imperative to delve into the various mechanisms through which circRNAs may contribute to the development and progression of the disease. Examining the current status of circRNA research in ALS and offering insights into their potential as therapeutic targets and diagnostic markers are the primary objectives of this review.